Frontline Innovation ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.0% 1.0% 1.0% 1.0% 1.0%  
Bankruptcy risk  14.9% 38.5% 15.1% 25.2% 38.1%  
Credit score (0-100)  15 0 12 2 0  
Credit rating  BB C BB B C  
Credit limit (kDKK)  0.0 -0.0 -0.0 -0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  1,495 415 774 -104 -681  
EBITDA  57.9 -359 52.7 -953 -1,452  
EBIT  25.7 -401 6.1 -1,013 -1,533  
Pre-tax profit (PTP)  -14.3 -451.6 -0.7 -900.8 -1,508.0  
Net earnings  -11.7 -463.7 109.9 -900.8 -1,618.6  
Pre-tax profit without non-rec. items  -14.3 -452 -0.7 -901 -1,508  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  17.5 8.8 105 77.9 520  
Shareholders equity total  10.8 -453 -304 -1,205 -2,823  
Interest-bearing liabilities  1.5 10.1 0.9 0.8 2.7  
Balance sheet total (assets)  1,433 535 1,307 758 2,783  

Net Debt  -339 -18.6 -33.0 -384 -59.4  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,495 415 774 -104 -681  
Gross profit growth  38.2% -72.2% 86.6% 0.0% -552.5%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,433 535 1,307 758 2,783  
Balance sheet change%  225.2% -62.7% 144.4% -42.0% 267.2%  
Added value  57.9 -358.9 52.7 -966.8 -1,452.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -10 -84 17 -122 328  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  2.0 -1.0 1.0 -1.0 -2.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  1.7% -96.6% 0.8% 970.5% 225.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  2.8% -33.1% 0.6% -49.2% -39.3%  
ROI %  124.0% -1,886.3% 39.6% -10,700.8% -84,330.8%  
ROE %  -70.3% -170.0% 11.9% -87.2% -91.4%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  0.8% -45.9% -22.3% -266.1% -169.1%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -585.5% 5.2% -62.7% 40.3% 4.1%  
Gearing %  14.1% -2.2% -0.3% -0.1% -0.1%  
Net interest  0 0 0 0 0  
Financing costs %  2,126.5% 872.9% 158.9% 2,579.3% 1,204.2%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.8 0.3 0.8 1.2 1.7  
Current Ratio  0.8 0.3 0.6 0.3 0.4  
Cash and cash equivalent  340.4 28.7 33.9 384.9 62.1  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -249.2 -661.6 -576.0 -1,430.7 -3,052.6  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  58 -359 53 -967 -1,452  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  58 -359 53 -953 -1,452  
EBIT / employee  26 -401 6 -1,013 -1,533  
Net earnings / employee  -12 -464 110 -901 -1,619